A 6 Month Safety Extension Study of MBGS205

Clinical trial NCT02908074 · COMPLETED

Trial details

NCT number: NCT02908074
Sponsor: Mereo BioPharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypogonadotropic Hypogonadism

Start date: 2016-11-15
Primary completion: 2018-09-08
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.